Coronavirus: Commission approves contract with CureVac to ensure access to a potential vaccine

This article is brought to you in association with the European Commission. Today, the European Commission approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to […]

Statement by President von der Leyen on CureVac

This article is brought to you in association with the European Commission. The coronavirus continues to spread rapidly across Europe. We need a safe and effective vaccine to end this pandemic. A few days after our contract with BioNTech and Pfizer, I am happy to announce a new agreement. Tomorrow, we will authorise a new contract […]

Commission and EIB provide CureVac with a €75 million financing for vaccine development and expansion of manufacturing

This article is brought to you in association with the European Commission. European Investment Bank and CureVac sign €75 million loan agreement for the development and large-scale production of vaccines, including CureVac’s vaccine candidate against SARS-CoV-2 The EIB loan will support CureVac’s activities to complete its new messenger ribonucleic acid (mRNA) production facility in Tübingen, Germany […]

Coronavirus: Commission offers financing to innovative vaccines company CureVac

This article is brought to you in association with the European Commission. Today, the Commission offered up to €80 million of financial support to CureVac, a higly innovative vaccine developer from Tübingen, Germany, to scale up development and production of a vaccine against the Coronavirus in Europe. Commission President Ursula von der Leyen and Commissioner for […]